Document Preview Unavailable

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study

Singh, Ravi Shankar P; Pradhan, Vivek; Roberts, Erika S; Scaramozza, Matthew; Kieras, Elizabeth; et al.  Clinical and Translational Science Vol. 14, Iss. 2,  (Mar 2021): 671-682.

You might have access to this document